This video, presented by psychiatrist Dr. Jandreer, provides an overview of suitable medications for ADHD therapy, addressing common myths and discussing the increasing diagnosis of ADHD in adulthood. The speaker clarifies that ADHD diagnosis in adults requires symptoms to have been present since childhood and discusses the evolution of understanding ADHD beyond just hyperactive boys. The core of the video details the four main substances used in treatment: Methylphenidate, Lisdexamfetamine, Atomoxetine, and Guanfacine. Methylphenidate is highlighted as the first choice, with a strong emphasis placed on debunking the myth of its addictiveness when used correctly in its slow-release formulation. The video distinguishes between amphetamine derivatives and non-amphetamine options, outlining the advantages, disadvantages, side effects, dosage guidelines, and clinical indications for each, including when second-line or non-stimulant options are preferred (e.g., with comorbidities like addiction or anxiety).
Understanding ADHD Medications: Options and Considerations for Adults
0:00 Introduction: The video discusses medications for ADHD therapy, addressing myths about Ritalin (Methylphenidate) and the rising prevalence of adult ADHD diagnoses.
0:56 Evolution of ADHD Diagnosis: Historically focused on hyperactive boys, the understanding expanded to include girls and non-hyperactive forms, and it is now recognized that ADHD often persists into adulthood.
2:16 Adult Diagnosis: Diagnosing ADHD in adults requires evidence of symptoms having been present during childhood, even if not formally diagnosed or treated at that time.
2:38 Methylphenidate (Ritalin) Myth: The myth that Methylphenidate is addictive like street amphetamines is addressed; in correct, slow-release dosages, it is released slowly, does not cause a "high," and research shows no addiction risk with proper use.
3:40 Correct Use Lowers Addiction Risk: Individuals with ADHD treated correctly with Methylphenidate actually have a lower risk of developing addiction later in life compared to untreated individuals.
4:28 Methylphenidate is First Choice: Clinical guidelines recommend Methylphenidate as the primary drug of choice for ADHD due to its efficacy and safety when used as intended.
6:25 Two Main Medication Groups: ADHD medications are categorized into amphetamine derivatives (Methylphenidate, Lisdexamfetamine) and non-amphetamines (Atomoxetine, Guanfacine). Amphetamines require controlled substance prescriptions.
Second amphetamine option, approved for children (from 6) and adults.
Used when Methylphenidate is not sufficiently effective or tolerated.
Pharmacology: Pro-drug converted to dextroamphetamine, slower release than MPD (slightly lower abuse risk if misused).
Dosage: Adults start 30mg/day, increase weekly to 20-70mg/day (max 70mg).
Side Effects: Can have more frequent side effects than MPD, particularly cardiovascular (increased blood pressure/pulse) and reduced appetite (potentially more common than with MPD). Caution with heart disease.
Non-amphetamine, selective noradrenaline reuptake inhibitor (an antidepressant, though not effective enough for depression treatment).
Effect Onset: Delayed, takes 2-4 weeks.
Preferred Choice When: Concurrent anxiety disorder, tic disorder, or addiction, as it has lower abuse potential than stimulants and benefits these comorbidities.
Dosage: Adults start 40mg/week, increase to 80-100mg/day (max 100mg). Children's dose based on body weight.
Side Effects: Increased blood pressure and heart rate are main concerns; requires monitoring.
Approved only for children and adolescents, not adults.
Effect Onset: Delayed, around 3 weeks.
Used in children/adolescents if stimulants are not tolerated.
22:15 Stimulant Abuse vs. Correct Use: Reiterate that the abuse potential of stimulants lies in misuse (e.g., crushing and snorting), not in the correct therapeutic use by diagnosed ADHD patients, which is shown to reduce future addiction risk.